Effect of Salovum™ and SPC-Flakes™ on Abemaciclib-induced Gastrointestinal Toxicity in Early Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Early-stage Breast Cancer|Diarrhea|Adverse Drug Event
Interventions: DRUG: SPC-flakes|DRUG: Salovum|DRUG: Placebo
Sponsor: Henrik Lindman